Cargando…
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in humans. There are factors that affect one’s TMAO level, such as diet, drugs, age, and hormones, among others. Gut dysbiosis in...
Autores principales: | Constantino-Jonapa, Luis A., Espinoza-Palacios, Yoshua, Escalona-Montaño, Alma R., Hernández-Ruiz, Paulina, Amezcua-Guerra, Luis M., Amedei, Amedeo, Aguirre-García, María M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952918/ https://www.ncbi.nlm.nih.gov/pubmed/36830968 http://dx.doi.org/10.3390/biomedicines11020431 |
Ejemplares similares
-
Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021) -
Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
por: Hai, Xin, et al.
Publicado: (2015) -
Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
por: Jia, Xun, et al.
Publicado: (2020) -
Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
por: Lombardo, Mauro, et al.
Publicado: (2021) -
Association of the Chronotype Score with Circulating Trimethylamine N-Oxide (TMAO) Concentrations
por: Barrea, Luigi, et al.
Publicado: (2021)